Perhaps I could comment as well about the model we use, which is really a collaborative model with jurisdictions to advance the adoption of best practices, and it's very much as has been raised.
For instance, we have a repository of guidelines on our portal cancerview.ca, and that repository can be shared with all the clinicians in the country. In addition, we have a capacity for collaborative spaces on the portal whereby clinicians from across the country can actually work together in a secure space to discuss the guidelines and their application. That would be available to anyone in the strategies we're discussing, because in fact it's a way of leveraging the investment the federal government's already made to increase collaboration in the country.
We are having a forum on lung cancer screening in November, where we're really looking at some new evidence of the ability to screen, and really asking questions with the provinces about what might be the best use of this technology.
Just to build on the previous witness's comment, we believe collaboration is absolutely critical in this country. It's a huge country with quite a small capacity, and we're going to get much further if we work together on some of these conditions and diseases.
Our coalitions very much focus on the full range of prevention efforts. In this first round of our coalitions, we are looking at how clinicians, physicians, can actually better counsel patients around these risk factors--this is through a joint effort in Ontario and Alberta. We'll learn how that goes, because some of it is really trying to learn how to actually effect change in many of these areas and it's not always clear. We might have the tools, but we don't seem to be having an impact, so how can we do better?
The fundamental part of it is to work with the jurisdictions, the clinicians, the charities, and the patient groups, actually working together to create solutions, implement them, evaluate them and learn from them.